LifeLines

Interviews, insights, and innovation leading the way for life science.

Innovations

From Bespoke to Scalable: How Companies Are Reinventing Cell Therapy

September 22, 2026

From Bespoke to Scalable: How Companies Are Reinventing Cell Therapy

Insights

Proposed Most Favored Nation Pricing Models Put Oncology Innovation at Risk

September 22, 2026

Proposed Most Favored Nation Pricing Models Put Oncology Innovation at Risk

Interviews

Member Spotlight: GeneFab

September 22, 2026

Member Spotlight: GeneFab

Involvement

Maravai LifeSciences in the Community

September 23, 2026

Maravai LifeSciences in the Community

Podcast

Episode 9: Engineering Antibodies Through AI and Machine Learning to Accelerate the Design of More Effective Treatments for Patients

August 2, 2023

Episode 9: Engineering Antibodies Through AI and Machine Learning to Accelerate the Design of More Effective Treatments for Patients

Your Story is Our Story

When it comes to CRISPR-based gene therapies, size isn’t just a detail—it’s a game-changer. Traditional gene editing relies on the Cas9 enzyme, a powerful tool but one with delivery and targeting challenges. Mammoth Biosciences is rewriting the rules with ultracompact Cas enzymes, enabling more precise in-vivo delivery, even in hard-to-reach tissues. Co-founded by CRISPR pioneer and Nobel laureate Jennifer Doudna, Ph.D., the company is moving beyond traditional gene splicing to develop more precise, controlled, and potentially safer therapies.

Join us for our video series, Your Story is Our Story, featuring groundbreaking achievements and exclusive behind-the-scenes looks at pioneering companies shaping the future of life science in California.

Learn More

#interviews

Interviews

Interviews

September 22, 2026

Member Spotlight: GeneFab

Interviews

July 29, 2026

Member Spotlight: Direct Biologics

Interviews

May 27, 2026

Member Spotlight: GATC Health

Member Spotlight

March 26, 2026

Member Spotlight: BrainChild Bio

Member Spotlight

January 29, 2026

Member Spotlight: Rosebud Biosciences

Insights

Policy Perspective

September 22, 2026

Proposed Most Favored Nation Pricing Models Put Oncology Innovation at Risk

Insights

August 18, 2026

A New Era for the SBIR/STTR Programs

Insights

July 29, 2026

Beyond Discovery: Where Capital is Flowing in Clinical AI

Insights

May 27, 2026

The Convergence of AI and Life Sciences Is Here

Insights

May 1, 2026

NCI SBIR/STTR STEP: Paving the Way to Non-Dilutive Federal Funding

Innovations

Trending Topic

September 22, 2026

From Bespoke to Scalable: How Companies Are Reinventing Cell Therapy

Trending Topic

July 29, 2026

Creating Confidence Before the Clinic

Trending Topic

May 27, 2026

The Companies Building the Next Era of Life Sciences With AI

March 25, 2026

When the Brain Catches Fire: Biotech’s New Approach to Neurological Disease

Trending Topic

February 4, 2026

Redefining Progress in Rare Disease: A Patient’s Perspective

Involvement

Involvement

September 23, 2026

Maravai LifeSciences in the Community

July 29, 2026

How MiraCosta College and Biocom Institute Are Strengthening the Biomanufacturing Workforce

May 27, 2026

Investing in Local Talent to Strengthen the Future of Food Safety

March 25, 2026

Connecting Science to the World Around Us: Neurocrine in the Community

Members in Action

March 3, 2026

San Diego Community Power: Commitment to the Community

Podcast

Season 1

August 2, 2023

Episode 9: Engineering Antibodies Through AI and Machine Learning to Accelerate the Design of More Effective Treatments for Patients

Season 1

July 19, 2023

Episode 8: Building a Collaborative Incubator Community for Orange County Biotech Startups

Season 1

July 5, 2023

Episode 7: Mapping the Growth of the Bay Area’s Life Science Industry and Providing Startups with the Tools to Scale and Seed

Season 1

June 21, 2023

Episode 6: Landing Multi-Million Dollar Partnerships for Next-Gen Gene Therapies While Addressing Gender Parity in Life Science Leadership

Season 1

June 7, 2023

Episode 5: Creating a Bridge from Higher Education to Real-Life Science Application as a First-Ever Female Dean

Premium Members